Works matching IS 15391604 AND DT 2024 AND VI 23 AND IP 6

Results: 28

Applying the Estimand Framework to Non‐Inferiority Trials.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1156, doi. 10.1002/pst.2433

By:

Lynggaard, Helle;
Keene, Oliver N.;
Mütze, Tobias;
Rehal, Sunita

Publication type:

Article

Bayesian Methods for Quality Tolerance Limit (QTL) Monitoring.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1166, doi. 10.1002/pst.2427

By:

Poythress, J. C.;
Lee, Jin Hyung;
Takeda, Kentaro;
Liu, Jun

Publication type:

Article

Efficient Study Design and Analysis of Longitudinal Dose–Response Data Using Fractional Polynomials.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1128, doi. 10.1002/pst.2425

By:

Hartley, Benjamin F.;
Lunn, Dave;
Mander, Adrian P.

Publication type:

Article

Bayesian Hierarchical Models for Subgroup Analysis.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1065, doi. 10.1002/pst.2424

By:

Wang, Yun;
Tu, Wenda;
Koh, William;
Travis, James;
Abugov, Robert;
Hamilton, Kiya;
Zheng, Mengjie;
Crackel, Roberto;
Bonangelino, Pablo;
Rothmann, Mark

Publication type:

Article

Reparametrized Firth's Logistic Regressions for Dose‐Finding Study With the Biased‐Coin Design.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1117, doi. 10.1002/pst.2423

By:

Kim, Hyungwoo;
Jung, Seungpil;
Pawitan, Yudi;
Lee, Woojoo

Publication type:

Article

Exploring Stratification Strategies for Population‐ Versus Randomization‐Based Inference.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1045, doi. 10.1002/pst.2419

By:

Novelli, Marco;
Rosenberger, William F.

Publication type:

Article

Variable Duration Trial as an Alternative Design for Continuous Endpoints.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1059, doi. 10.1002/pst.2418

By:

Ganju, Jitendra;
Ma, Julie Guoguang

Publication type:

Article

A Personalized Dose‐Finding Algorithm Based on Adaptive Gaussian Process Regression.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1181, doi. 10.1002/pst.2417

By:

Park, Yeonhee;
Chang, Won

Publication type:

Article

Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference‐Base Centred Multiple Imputation.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1095, doi. 10.1002/pst.2416

By:

Cro, Suzie;
Roger, James H.;
Carpenter, James R.

Publication type:

Article

T3 + 3: 3 + 3 Design With Delayed Outcomes.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 959, doi. 10.1002/pst.2414

By:

Guo, Jiaying;
Lu, Mengyi;
Wan, Isabella;
Wang, Yumin;
Han, Leng;
Zang, Yong

Publication type:

Article

Survival Analysis Without Sharing of Individual Patient Data by Using a Gaussian Copula.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1031, doi. 10.1002/pst.2415

By:

Bonofiglio, Federico

Publication type:

Article

Optimal Cut‐Point Selection Methods Under Binary Classification When Subclasses Are Involved.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 984, doi. 10.1002/pst.2413

By:

Wang, Jia;
Tian, Lili

Publication type:

Article

To Dilute or Not to Dilute: Nominal Titer Dosing for Genetic Medicines.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 939, doi. 10.1002/pst.2406

By:

Faya, Paul;
Zhang, Tianhui

Publication type:

Article

Estimation of Treatment Policy Estimands for Continuous Outcomes Using Off‐Treatment Sequential Multiple Imputation.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1144, doi. 10.1002/pst.2411

By:

Drury, Thomas;
Abellan, Juan J.;
Best, Nicky;
White, Ian R.

Publication type:

Article

Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 971, doi. 10.1002/pst.2410

By:

Fougeray, Ronan;
Vidot, Loïck;
Ratta, Marco;
Teng, Zhaoyang;
Skanji, Donia;
Saint‐Hilary, Gaëlle

Publication type:

Article

Investigating Stability in Subgroup Identification for Stratified Medicine.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 945, doi. 10.1002/pst.2409

By:

Hair, G. M.;
Jemielita, T.;
Mt‐Isa, S.;
Schnell, P. M.;
Baumgartner, R.

Publication type:

Article

Sample Size Estimation Using a Partially Clustered Frailty Model for Biomarker‐Strategy Designs With Multiple Treatments.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1084, doi. 10.1002/pst.2407

By:

Dinart, Derek;
Rondeau, Virginie;
Bellera, Carine

Publication type:

Article

Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 1206, doi. 10.1002/pst.2412

By:

Dyachkova, Yulia;
Dunger‐Baldauf, Cornelia;
Barbier, Nathalie;
Devenport, Jenny;
Franzén, Stefan;
Kazeem, Gbenga;
Künzel, Thomas;
Mancini, Pierre;
Mordenti, Giacomo;
Richert, Knut;
Ridolfi, Antonia;
Saure, Daniel

Publication type:

Article

Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 928, doi. 10.1002/pst.2398

By:

Garcia Barrado, Leandro;
Burzykowski, Tomasz

Publication type:

Article

Covariate adjustment and estimation of difference in proportions in randomized clinical trials.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 884, doi. 10.1002/pst.2397

By:

Liu, Jialuo;
Xi, Dong

Publication type:

Article

A model‐assisted design for partially or completely ordered groups.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 906, doi. 10.1002/pst.2396

By:

Celum, Connor;
Conaway, Mark

Publication type:

Article

Current developments of the estimand concept.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 864, doi. 10.1002/pst.2395

By:

Fierenz, Alexander;
Zapf, Antonia

Publication type:

Article

Optimal sample size division in two‐stage seamless designs.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 854, doi. 10.1002/pst.2394

By:

Berry, Lindsay R.;
Marion, Joe;
Berry, Scott M.;
Viele, Kert

Publication type:

Article

Comparing various Bayesian random‐effects models for pooling randomized controlled trials with rare events.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 837, doi. 10.1002/pst.2392

By:

Yao, Minghong;
Jia, Yulong;
Mei, Fan;
Wang, Yuning;
Zou, Kang;
Li, Ling;
Sun, Xin

Publication type:

Article

Tree‐temporal scan statistics for safety signal detection in vaccine clinical trials.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 813, doi. 10.1002/pst.2391

By:

Haguinet, François;
Tibaldi, Fabian;
Dessart, Christophe;
Bate, Andrew

Publication type:

Article

Mathematical programming tools for randomization purposes in small two‐arm clinical trials: A case study with real data.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 794, doi. 10.1002/pst.2388

By:

Vazquez, Alan R.;
Wong, Weng‐Kee

Publication type:

Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 791, doi. 10.1002/pst.2312
Publication type:: Article

Visualizing hypothesis tests in survival analysis under anticipated delayed effects.

Published in:

Pharmaceutical Statistics, 2024, v. 23, n. 6, p. 870, doi. 10.1002/pst.2393

By:

Jiménez, José L.;
Barrott, Isobel;
Gasperoni, Francesca;
Magirr, Dominic

Publication type:

Article